4.0 EXCLUSION CRITERIA 
The following conditions/situations will render patients ineligible for this study: 
4.1 Serious intercurrent medical illnesses, to include significant cardiac 
disease (New York Heart Association Class III or IV), angina pectoris, or 
myocardial infarction within the previous 6 months. 
4.2 The presence of an active infection, including urinary tract infection. 
4.3 The presence of active intracranial or multiple hepatic metastases. 
4.4 Pregnant or lactating women. 
4.5 Patients who have received more than two regimens of systemic 
chemotherapy. Use of low dose cyclophosphamide as part of a previous 
tumor vaccination program shall not constitute a prior systemic 
chemotherapy regimen. 
4.6 Patients requiring continuing therapy with corticosteroids will not be 
eligible. 
5.0 CONCURRENT THERAPY 
The following therapies are prohibited while patients are being treated on this protocol: 
radiation therapy, chemotherapy, corticosteroids (except as administered for life- 
threatening circumstances), or other immunotherapy. 
6.0 PRETREATMENT EVALUATION 
6.1 History and physical examination, including documentation of all 
measurable disease. 
6.2 Height, weight, and performance status. 
6.3 Screening profile, BUN, and creatinine. 
6.4 CBC, differential, and platelet count. 
6.5 Chest X-ray. 
6.6 EKG 
Recombinant DNA Research, Volume 15 
[897] 
